Nonspecific neck pain

Nonspecific neck pain (NSNP) is neck pain without an identifiable pathological cause such as fracture, malignancy, infection, inflammatory arthritis, or neurological deficit. It is one of the most common musculoskeletal complaints in general practice, with a global point prevalence of approximately 10% and a lifetime prevalence exceeding 70%. The vast majority of neck pain presentations in primary care are nonspecific in nature.

NSNP encompasses axial neck pain that may radiate to the occiput, shoulder girdle, or upper arm in a non-dermatomal pattern. It does not include cervical radiculopathy, myelopathy, whiplash-associated disorder (WAD), or neck pain attributable to specific structural pathology. In Australian general practice, NSNP is frequently linked to sustained postures, sedentary work, psychosocial stressors, and deconditioning.

Management is centred on active, self-directed strategies. Reassurance, pain neuroscience education, exercise, and addressing psychosocial contributors form the evidence-based core of treatment. Imaging is not routinely indicated and does not improve outcomes in NSNP. Opioids are not indicated. This guideline aligns with Australian RACGP, NICE, and Choosing Wisely Australia recommendations.

The cervical spine is a mechanically complex structure supporting the head while providing a wide range of motion. NSNP arises from sensitisation of nociceptive afferents in the cervical facet joints, intervertebral discs, musculature, ligaments, and fascia. There is no single identifiable structural lesion.

Peripheral sensitisation occurs through sustained mechanical loading, microtrauma, and local inflammatory mediators. Central sensitisation — heightened spinal cord and supraspinal pain processing — is particularly relevant in chronic NSNP and is reflected in expanded pain referral patterns, allodynia, and hyperalgesia. Central sensitisation is associated with poor psychosocial factors (catastrophising, fear-avoidance, depression, anxiety) and is a major driver of chronicity.

Postural and ergonomic factors — prolonged forward head posture, sustained static loading during screen-based work — increase facet joint loading and paravertebral muscle fatigue. However, imaging findings such as disc degeneration or osteophytes are ubiquitous in the general population and correlate poorly with pain severity, making them unreliable as explanatory findings in NSNP.

Psychosocial yellow flags (fear of movement, negative pain beliefs, work dissatisfaction, low mood) are the strongest predictors of chronicity and disability in NSNP. This biopsychosocial model underpins the evidence-based management approach.

NSNP presents as axial neck pain without neurological signs or symptoms. The clinical history and examination are directed at confirming the nonspecific diagnosis, excluding specific pathology and red flags, and identifying psychosocial contributors.

Red flag assessment is mandatory at first presentation. Red flags requiring urgent assessment include: recent significant trauma (fracture/instability risk); night pain or rest pain without mechanical provocation; fever, weight loss, or systemic illness (infection/malignancy); history of malignancy; immunosuppression or IV drug use; upper motor neurone signs (spasticity, hyperreflexia, clonus, bilateral upper limb symptoms); progressive neurological deficit; new bladder or bowel dysfunction (myelopathy); neck stiffness with photophobia or fever (meningism).

Yellow flag screening should be performed at first presentation and reviewed at 6 weeks if pain persists. Key yellow flags include: catastrophic thinking, fear-avoidance behaviour, passive coping strategies, low mood or anxiety, poor work satisfaction, and belief that pain must resolve before resuming activity.

Examination findings consistent with NSNP: restricted or painful cervical range of motion without neurological deficit; tender paravertebral musculature; reproduction of pain with sustained posture or axial loading. Normal upper limb neurology distinguishes NSNP from radiculopathy.

Investigations are not routinely indicated in NSNP. Imaging and laboratory investigations are reserved for cases where red flags are identified or where the clinical course is atypical.

Severity classification in NSNP guides management intensity and identifies patients at risk of chronicity. The Neck Disability Index (NDI) is the most widely validated tool. A brief yellow flag screen (Örebro MSK Pain Screening Questionnaire or STarT MSK) provides prognostic information.

The evidence base for NSNP management strongly favours active, patient-centred approaches over passive treatments. The cornerstone of management is reassurance that NSNP is not dangerous, combined with structured encouragement to remain active and address modifiable contributors.

• Reassurance and pain education: Explain the biopsychosocial model. Address fear that pain equals structural damage. Pain neuroscience education reduces catastrophising and improves outcomes. Avoid language that increases fear (e.g., “wear and tear”, “crumbling disc”).
• Stay active: Advise continuation of all usual activities within pain tolerance. Bed rest and avoidance of activity worsen outcomes. Graduated return to normal activities is superior to rest.
• Exercise: Supervised cervical strengthening and stabilisation exercises are the most evidence-based intervention for NSNP. Aerobic exercise and yoga also have supporting evidence. Physiotherapy referral recommended for moderate–severe presentations.
• Postural and ergonomic advice: Workstation modification for screen-based workers. Avoid prolonged forward head posture. Microbreaks and movement variation during work.
• Psychological strategies: CBT, acceptance-commitment therapy (ACT), and mindfulness-based approaches are indicated when significant yellow flags are present.
• Manual therapy: Cervical manipulation and mobilisation may provide short-term pain relief as an adjunct to exercise but should not be the sole treatment. Risk–benefit discussion required for manipulation.
• Avoid passive dependency: Collar use, prolonged rest, over-reliance on manual therapy, and TENS as primary treatment do not improve long-term outcomes and may reinforce fear-avoidance.

Pharmacotherapy plays a limited adjunctive role in NSNP. Analgesics are used short-term to facilitate participation in active rehabilitation. They should not be the primary or sole treatment strategy.

Acute NSNP (duration <6 weeks) has an excellent prognosis with appropriate early management. The majority of patients recover within 6–12 weeks. Early active management reduces risk of chronicity.

• Reassure regarding good prognosis; explain pain neuroscience; address specific fears about damage or disease.
• Advise continuation of usual activities; prescribe graduated exercise (begin with gentle cervical range-of-motion, progress to strengthening); avoid passive rest.
• Analgesia if required: paracetamol first-line; NSAIDs second-line for short-term use; muscle relaxant (diazepam) only for severe acute muscle spasm, maximum 7 days.
• Physiotherapy referral: recommended for moderate–severe acute pain or physically demanding occupations; exercise prescription, manual therapy adjunct, education.
• Yellow flag screening at first presentation; early psychology referral if significant yellow flags detected.
• Heat application: short-term heat packs may provide symptomatic relief and facilitate movement; safe adjunct to active management.
• Review at 6 weeks: if pain persists or worsens, reassess for red flags, review yellow flags, consider imaging if red flags have emerged.

Monitoring in NSNP focuses on symptom trajectory, functional recovery, identification of chronicity risk, and reassessment of yellow flags and medication safety.

Certain population groups require modified management approaches for NSNP.

Aboriginal and Torres Strait Islander peoples face additional barriers to accessing evidence-based musculoskeletal care, with higher rates of chronic pain, psychosocial adversity, and healthcare access inequity. Culturally safe and community-centred management of NSNP is essential.

Medication stewardship in NSNP is principally focused on analgesic stewardship — avoiding opioid prescribing, limiting NSAID and muscle relaxant duration, and supporting deprescription where analgesics have been inappropriately escalated.

The GP’s stewardship role includes education at each visit that active management, not medicines, is the primary treatment for NSNP.

Follow-up for nonspecific neck pain is symptom-guided and outcome-focused. Prevention of recurrence and chronicity through ongoing self-management is the key long-term goal.

• Hoy DG et al. — The global burden of neck pain: estimates from the Global Burden of Disease 2010 study; Ann Rheum Dis 2014
• Gross A et al. — Manipulation and mobilisation for neck pain contrasted against an inactive control or another active treatment; Cochrane Database Syst Rev 2015
• Kay TM et al. — Exercises for mechanical neck disorders; Cochrane Database Syst Rev 2012
• Linton SJ, Shaw WS — Impact of psychological factors in the experience of pain; Phys Ther 2011
• RACGP — Prescribing drugs of dependence in general practice; 2017
• Choosing Wisely Australia — Imaging for nonspecific neck pain; 2020
• National Institute for Health and Care Excellence (NICE) — Neck pain: non-specific; 2022
• Therapeutic Guidelines: Musculoskeletal — Neck pain; available via eTG complete
• Brison RJ et al. — A randomised controlled trial of an educational intervention to prevent the chronic pain of whiplash associated disorders following rear-end motor vehicle collisions; Spine 2005